UNIVERSITY OF WASHINGTON

The University of Washington specializes in advanced genomic research and biological data analysis, with deep technical expertise in high-throughput DNA sequencing, genome assembly, and next-generation sequencing platform operations. Their work centers on applying cutting-edge sequencing technologies—such as PacBio Revio—to generate high-coverage, long-read genomic datasets for complex biological samples, enabling precision insights in human health and agricultural genomics. Key differentiators include expertise in SMRTbell library preparation, 30x coverage sequencing workflows, and the integration of genomic data into actionable research outputs for federal science missions. Their capabilities span the full lifecycle of genomic experimentation, from sample processing to data generation, with a focus on reproducibility and scalability in controlled research environments. The contractor maintains a consistent and primary relationship with the Department of Veterans Affairs, delivering genomic research services that support veteran health studies, likely including population-scale sequencing for disease susceptibility, aging, and trauma-related biomarkers. A secondary engagement with the Department of Agriculture involves plant genomics, specifically wheat genome characterization using advanced sequencing platforms, indicating capacity to adapt genomic methodologies across human and agricultural domains. Their primary focus lies in NAICS 541715, which encompasses foundational physical and life sciences research, particularly in genomics and molecular biology, and NAICS 541714, where they apply biotechnological tools to agricultural systems. This positions them as a research-intensive academic contractor bridging biomedical and agricultural science with federal priorities in precision health and food security. As a university-based entity with a 2A structure, the University of Washington operates as a non-profit research institution headquartered in Seattle, WA, with no federal certifications on record. Their government market presence is defined by deep scientific credibility, institutional research infrastructure, and a proven ability to execute complex, federally funded life sciences projects without reliance on small business or minority certifications.